ARCHIVES

CMS Looks At Coverage of Two Agents Approved on Surrogate Endpoints

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | March 21, 2003

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Cancer Center, Cooperative Group Trials

December 28, 2007

House Completes Committee Lineups

February 18, 1977

Groups’ Growth, Impact Shown by Five-Year Data

March 3, 1978

DCE Concepts Statements

March 11, 1988

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

April 27, 2001

Trial Data: No Benefit In Adding Perifosine to Capecitabine

June 29, 2012